Barclays Maintains Overweight on Alvotech, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad maintains an Overweight rating on Alvotech (NASDAQ:ALVO) and raises the price target from $20 to $22.
May 24, 2024 | 3:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Balaji Prasad maintains an Overweight rating on Alvotech and raises the price target from $20 to $22.
The raised price target and maintained Overweight rating from a reputable analyst at Barclays is likely to positively impact investor sentiment and drive short-term price appreciation for Alvotech.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100